Gts Securities LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $1.12 Million - $1.38 Million
15,000 Added 29.82%
65,300 $5.38 Million
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $1.06 Million - $1.26 Million
12,700 Added 33.78%
50,300 $4.39 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $1.28 Million - $1.65 Million
16,800 Added 80.77%
37,600 $3.63 Million
Q3 2023

Nov 15, 2023
BUY
$85.07 - $94.48 $1.77 Million - $1.97 Million
20,800 New
20,800 $1.84 Million

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email